Compare Verisign, Inc. (VRSN) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Verisign, Inc. vs DENTSPLY SIRONA Inc — how do they compare? Verisign, Inc. trades at $303.74 (market cap $26.92B), while DENTSPLY SIRONA Inc trades at $8.83 (market cap $1.73B). The key difference: Verisign, Inc. is far larger — about 15.6× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals — on Pluang, investors hold Verisign, Inc. for 123 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| VRSN | XRAY | |
|---|---|---|
Market Cap | $26.92B | $1.73B |
Volume | 1,921,402 | 6,198,582 |
Sector | Technology | Health |
52-Week High | $310.00 | $14.68 |
52-Week Low | $211.49 | $8.52 |
Typical Hold Time | 123 Days | 72 Days |
Enterprise Value | $28.23B | $3.80B |
Dividend Yield | 1.09% | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VeriSign (VRSN) trades at $297.79, up 1.21% today, with a bullish technical signal and strong institutional interest. The company reported Q2 2026 EPS of $2.38, missing estimates, but maintains robust fundamentals with a 49.77% net income margin and $1.66B revenue in 2025. Recent news includes an upcoming Q3 earnings call and insider sales by the CEO, while an antitrust lawsuit poses a regulatory overhang.
The outlook remains positive with a consensus price target of $348, implying 17% upside, supported by steady cash flow growth and domain registration strength. Key risks include legal challenges and competitive pressures, but analyst sentiment is predominantly bullish with 60% buy ratings.
DENTSPLY SIRONA (XRAY) trades at $8.69, near its 52-week low, with a bearish technical signal from moving averages. The company reported a Q2 2026 earnings beat but faces declining revenue and negative net income margins. Recent news highlights institutional stake increases and ongoing restructuring efforts amid weak dental market conditions.
The outlook remains challenging with persistent profitability issues and high debt levels, though analyst consensus suggests upside potential with a $13 price target. Key risks include margin pressure and competitive threats, requiring careful monitoring of the company's turnaround execution for any recovery signs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
